vimarsana.com
Home
Live Updates
Shanghai Shenkang Clinical Innovation Project - Breaking News
Pages:
Latest Breaking News On - Shanghai shenkang clinical innovation project - Page 1 : vimarsana.com
Possible Salvage Option for Refractory/Recurrent CNS Lymphoma
An effective salvage regimen is lacking for these patients. This study shows cytarabine plus temozolomide may be an option. The study was published as a preprint and has not yet been peer reviewed.
Shanghai shenkang clinical innovation project
Non hodgkins lymphoma
Central nervous system lymphoma
Primary cns lymphoma
Primary central nervous system lymphoma
Human leukocyte antigen
La human leukocyte antigen
Peer review
vimarsana © 2020. All Rights Reserved.